These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 32956660)
1. Leukotriene D Al-Azzam N; Elsalem L Life Sci; 2020 Nov; 260():118452. PubMed ID: 32956660 [TBL] [Abstract][Full Text] [Related]
2. Identification of cysteinyl-leukotriene-receptor 1 antagonists as ligands for the bile acid receptor GPBAR1. Biagioli M; Carino A; Marchianò S; Roselli R; Di Giorgio C; Bordoni M; Fiorucci C; Sepe V; Conflitti P; Limongelli V; Distrutti E; Baldoni M; Zampella A; Fiorucci S Biochem Pharmacol; 2020 Jul; 177():113987. PubMed ID: 32330496 [TBL] [Abstract][Full Text] [Related]
3. Comparison study between the mechanisms of allergic asthma amelioration by a cysteinyl-leukotriene type 1 receptor antagonist montelukast and methylprednisolone. Murai A; Abe M; Hayashi Y; Sakata N; Katsuragi T; Tanaka K J Pharmacol Exp Ther; 2005 Feb; 312(2):432-40. PubMed ID: 15470084 [TBL] [Abstract][Full Text] [Related]
4. Effect of a cysteinyl leukotriene receptor antagonist on experimental emphysema and asthma combined with emphysema. Ikeda G; Miyahara N; Koga H; Fuchimoto Y; Waseda K; Kurimoto E; Taniguchi A; Tanimoto Y; Kataoka M; Tanimoto M; Kanehiro A Am J Respir Cell Mol Biol; 2014 Jan; 50(1):18-29. PubMed ID: 23937413 [TBL] [Abstract][Full Text] [Related]
5. Inhaled montelukast inhibits cysteinyl-leukotriene-induced bronchoconstriction in ovalbumin-sensitized guinea-pigs: the potential as a new asthma medication. Muraki M; Imbe S; Sato R; Ikeda Y; Yamagata S; Iwanaga T; Tohda Y Int Immunopharmacol; 2009 Oct; 9(11):1337-41. PubMed ID: 19706339 [TBL] [Abstract][Full Text] [Related]
6. Pharmacology of leukotriene receptor antagonists. Aharony D Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 2):S214-8; discussion S218-9, S247-8. PubMed ID: 9647602 [TBL] [Abstract][Full Text] [Related]
7. Leukotriene receptor antagonist attenuated airway inflammation and hyperresponsiveness in a double-stranded RNA-induced asthma exacerbation model. Ujino M; Sugimoto N; Koizumi Y; Ro S; Kojima Y; Asae KH; Yamashita N; Ohta K; Nagase H Allergol Int; 2017 Sep; 66S():S21-S26. PubMed ID: 28647381 [TBL] [Abstract][Full Text] [Related]
8. [Zafirlukast (Accolate): a review of its pharmacological and clinical profile]. Murata Y; Sugimoto O Nihon Yakurigaku Zasshi; 2002 Apr; 119(4):247-58. PubMed ID: 11979731 [TBL] [Abstract][Full Text] [Related]
13. Identification of GPR99 protein as a potential third cysteinyl leukotriene receptor with a preference for leukotriene E4 ligand. Kanaoka Y; Maekawa A; Austen KF J Biol Chem; 2013 Apr; 288(16):10967-72. PubMed ID: 23504326 [TBL] [Abstract][Full Text] [Related]
14. [The role of leukotrienes in inflammation and leukotriene inhibitors]. Kupczyk M; Kuna P Pol Merkur Lekarski; 1999 Sep; 7(39):85-93. PubMed ID: 10598480 [TBL] [Abstract][Full Text] [Related]
15. Neutralization of leukotriene C4 and D4 activity by monoclonal and single-chain antibodies. Kawakami Y; Hirano S; Kinoshita M; Otsuki A; Suzuki-Yamamoto T; Suzuki M; Kimoto M; Sasabe S; Fukushima M; Kishimoto K; Izumi T; Oga T; Narumiya S; Sugahara M; Miyano M; Yamamoto S; Takahashi Y Biochim Biophys Acta; 2014 Jun; 1840(6):1625-33. PubMed ID: 24361619 [TBL] [Abstract][Full Text] [Related]
16. Leukotriene D Liu T; Barrett NA; Nagai J; Lai J; Feng C; Boyce JA J Allergy Clin Immunol; 2021 Jul; 148(1):195-208.e5. PubMed ID: 33285161 [TBL] [Abstract][Full Text] [Related]